Telemedicine Talks

#67 - Your License at Risk: How Zealthy Used Doctors’ Names Without Their Knowledge

Episode Summary

Join Phoebe Gutierrez and Dr. Leo Damasco on Telemedicine Talks as they break down the FTC and DOJ actions against Zealthy (Z-E-A-L-T-H-Y), a GLP-1 telehealth company founded by Cerebral’s former CEO. From deceptive billing and subscription traps to prescriptions written under doctors’ names without their knowledge, this case highlights major risks in telehealth. Learn why due diligence matters for clinicians, the dangers of ghost PC owners, and practical steps to protect your license in corporate practice of medicine (CPOM) setups.

Episode Notes

What happens when a telehealth founder moves from one controversy to the next, and doctors’ licenses get caught in the crossfire?

In this episode of Telemedicine Talks, hosts Phoebe Gutierrez and Dr. Leo Damasco dive into the latest FTC/DOJ actions against Zealthy, a GLP-1 and lifestyle telehealth company led by Kyle Robertson (former CEO of Cerebral). They discuss allegations of deceptive marketing, hidden subscription charges, and most alarmingly, using physicians’ names and NPIs to issue prescriptions without the doctors’ awareness or involvement.

The conversation explores broader issues in telemedicine: the lack of upfront regulatory oversight for new companies, escalation of commitment in non-compliant operations, risks to PC owners and supervising physicians, and why physicians must actively engage in clinical oversight rather than taking passive roles. Phoebe and Leo emphasize the importance of proper CPOM structures, due diligence, and building compliant operations where physicians stay in the driver’s seat.

This episode provides actionable advice for clinicians considering telehealth opportunities and a reminder that compliant, well-run models can still deliver strong results when done right.

Top 3 Takeaways:

About the Show:

Telemedicine Talks explores the evolving world of digital health, helping physicians navigate new opportunities, regulatory challenges, and career transitions in telemedicine.

About the Hosts: